Australian Research. Global Outcomes.

ADDRI is an independent, not-for-profit research institute committed to reducing and ultimately eliminating the impact of asbestos and dust-related diseases worldwide.

What we do

We work in collaboration with individuals and organisations dedicated to eradicating asbestos and dust-related diseases while providing personalised and wrap-around support to those affected by them.

Learn more


Our evidence-led research drives advancements in medical and scientific understanding and guides our global education and training initiatives.

Our work

Featured Researcher

A/Professor Steven Kao

Dr Steven Kao is a Medical Oncology Staff Specialist at the Chris O’Brien Lifehouse, Royal Prince Alfred Hospital since 2013, where he has overseen the thoracic oncology clinical service, particularly the programme of malignant mesothelioma.

Steven has a wide clinical, translational, and psycho-social research interest in thoracic cancers including malignant mesothelioma and asbestos-related lung cancer.

Steven completed his PhD at ADDRI and Sydney University in 2013. His research was focused on predictive and prognostic factors in malignant mesothelioma. With his continuing affiliation at ADDRI, he has continued his translational research in biomarkers and novel therapeutic targets in malignant mesothelioma. He has had several grants as a principal investigator in the field of mesothelioma. He was instrumental in completing the first-in-man phase I trial using a novel delivery system to replace miR15/16 in mesothelioma patients, sponsored by ADDRI.

Steven has received many awards in recognition of his research. These include: the Excellence in Translational Cancer Research in the 2014 Premier’s Awards for Outstanding Cancer Research, Cancer Institute NSW; and, the Outstanding Cancer Research Scholar in the 2012 Premier’s Award for Outstanding Cancer Research, Cancer Institute NSW.

The Research Team
background blob pattern


We are on a mission to educate that asbestos is a very real threat to people all over the world.



Bringing together over 60 specific topics and written in collaboration with 100 global
experts, this online education resource provides a comprehensive guide in how to diagnose
and treat asbestos-related diseases.

Learn more

Learning Modules

Nurses and allied health professionals can access our Specialist Mesothelioma eLearning
resource. This comprehensive one-stop resource is designed as a 30-minute module,
following a chronological timeline in a patient’s mesothelioma journey.

Learn more


Listening to people’s stories is very powerful. If you have been diagnosed – or are caring for
someone who has – we have a series of inspiring conversations to offer information,
understanding and hope.

Learn more
background blob pattern


Have you been impacted?

We have a dedicated and compassionate team of specialist registered nurses who can provide you with the most current clinical information, referral pathways and emotional support via phone and email as well as a number of peer support groups. We're here to help you.

background blob pattern


Trevor's Story

When Trevor and his wife Shirley returned home to Australia after being overseas feeling increasingly breathless, Trevor received a call that would change his life forever.

Read more

Research Projects

Working towards early diagnosis

This project aims to identify and validate new blood-based biomarkers to facilitate an improved and less invasive diagnosis of mesothelioma.

Read more


Raul's story

Raúl Antonio Medina Ortiz worked as a Logistics Assistant for over 14 years for Incolbest SA, a company in Colombia manufacturing parts for vehicle brakes.

Read more


An Indonesian Story

Tuniah and Kuswoyo worked for the Trigraha Sealsindo company, an asbestos manufacturer for automotive parts in Indonesia for over 20 years.

Read more

Our supporters

Our ability to advance our research is only made possible through the generosity of our supporters and collaboration with organisations and individuals dedicated to eradicating asbestos and dust related diseases.

Learn more

Sign up to our newsletter

Sign up
Skip to content